Martino, Cameron http://orcid.org/0000-0001-9334-1258
Zaramela, Livia S. http://orcid.org/0000-0002-1065-3799
Gao, Bei http://orcid.org/0000-0002-3321-2339
Embree, Mallory
Tarasova, Janna
Parker, Seth J. http://orcid.org/0000-0001-7971-8848
Wang, Yanhan
Chu, Huikuan
Chen, Peng
Lee, Kuei-Chuan
Galzerani, Daniela Domingos
Gengatharan, Jivani M.
Lekbua, Asama
Neal, Maxwell
Knight, Rob http://orcid.org/0000-0002-0975-9019
Tsukamoto, Hidekazu
Metallo, Christian M.
Schnabl, Bernd
Zengler, Karsten http://orcid.org/0000-0002-8062-3296
Funding for this research was provided by:
Pilot&Feasibility grant from the Southern California Research Center for ALDP and Cirrhosis
Article History
Received: 19 November 2020
Accepted: 8 July 2022
First Online: 8 August 2022
Competing interests
: B.S. has been consulting for Ferring Research Institute, Gelesis, HOST Therabiomics, Intercept Pharmaceuticals, Mabwell Therapeutics, Patara Pharmaceuticals and Takeda. B.S.’s institution UC San Diego has received research support from Axial Biotherapeutics, BiomX, CymaBay Therapeutics, NGM Biopharmaceuticals, Prodigy Biotech and Synlogic Operating Company. B.S. is founder of Nterica Bio. UC San Diego has filed several patents with B.S. as an inventor related to this work. The remaining authors declare no competing interests.